Itamar Raz
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management 142
- Diabetes Management and Research 97
- Diabetes, Cardiovascular Risks, and Lipoproteins 38
- Nephrology top 0.1%
- Pharmacology top 0.2%
- Pharmacology and Obesity Treatment 26
- Physiology top 0.5%
- Diet and metabolism studies 27
-
- Metabolism, Diabetes, and Cancer 75
-
- Pancreatic function and diabetes 55
-
- Diabetes and associated disorders 40
Itamar Raz
364 papers receiving 25.0k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Endocrinology, Diabetes and Metabolism 15.2k
- Nephrology 3.0k
- Cardiology and Cardiovascular Medicine 6.4k
- Pharmacology 2.2k
- Physiology 3.3k
Countries citing papers authored by Itamar Raz
This map shows the geographic impact of Itamar Raz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itamar Raz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itamar Raz more than expected).
Fields of papers citing papers by Itamar Raz
This network shows the impact of papers produced by Itamar Raz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itamar Raz. The network helps show where Itamar Raz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Itamar Raz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | Overview of oxidative stress and inflammation in diabetesbreakdown → | 2024 | 66 |
| 3 | 2023 | 4 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 19 | |
| 6 | 2022 | 43 | |
| 7 | Assessing reproducibility and utility of clustering of patients with type 2 diabetes and established CV disease (SAVOR -TIMI 53 trial) | 2021 | 1 |
| 8 | 2021 | 0 | |
| 9 | 2021 | 30 | |
| 10 | 2021 | 44 | |
| 11 | 2021 | 49 | |
| 12 | Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitusbreakdown → | 2020 | 313 |
| 13 | 2020 | 3 | |
| 14 | Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitusbreakdown → | 2019 | 534 |
| 15 | 2019 | 235 | |
| 16 | Abstract 15670: Relationship Between Baseline Cardiac Biomarkers and Cardiovascular Death or Hospitalization for Heart Failure in DECLARE-TIMI 58 | 2019 | 2 |
| 17 | 2012 | 12 | |
| 18 | 2006 | 140 | |
| 19 | 2006 | 19 | |
| 20 | High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among overweight Arabs in Israel. | 2005 | 30 |
About Itamar Raz
Itamar Raz is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine, having authored 374 papers that have together received 26.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (142 papers), Diabetes Management and Research (97 papers), Metabolism, Diabetes, and Cancer (75 papers), Pancreatic function and diabetes (55 papers), Diabetes and associated disorders (40 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Diet and metabolism studies (27 papers) and Pharmacology and Obesity Treatment (26 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (15.2k citations), Nephrology (3.0k citations) and Cardiology and Cardiovascular Medicine (6.4k citations). Itamar Raz has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Ofri Mosenzon, Tomás Berl, Edmund J. Lewis, Julia B. Lewis, Lawrence G. Hunsicker, Deepak L. Bhatt, Marc A. Pohl, Robert C. Atkins, Richard Rohde and William R. Clarke. Their work appears in journals such as Diabetes Care, Diabetes/Metabolism Research and Reviews, Circulation, Diabetes and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.